On Thursday, 29 May 2025, Elanco Animal Health (NYSE:ELAN) took the stage at the Stifel Jaws & Paws Conference 2025. The company showcased its strategic focus on growth through innovation and cash generation while addressing challenges like pharmaceutical tariffs. Elanco's leadership emphasized a proactive approach to leadership changes and debt management, highlighting both achievements and areas for improvement.